These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27468167)

  • 1. Management of type 2b von Willebrand disease in the neonatal period.
    Proud L; Ritchey AK
    Pediatr Blood Cancer; 2017 Jan; 64(1):103-105. PubMed ID: 27468167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in type 2B VWD: a case series.
    Ranger A; Manning RA; Lyall H; Laffan MA; Millar CM
    Haemophilia; 2012 May; 18(3):406-12. PubMed ID: 22077376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and therapeutic management in a patient with type 2B-like acquired von Willebrand syndrome.
    Karger R; Weippert-Kretschmer M; Budde U; Kretschmer V
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):144-7. PubMed ID: 21178586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired von Willebrand syndrome with a type 2B phenotype: diagnostic and therapeutic dilemmas.
    Scepansky E; Othman M; Smith H
    Acta Haematol; 2014; 131(4):213-7. PubMed ID: 24296552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.
    Stufano F; Baronciani L; Pagliari MT; Franchi F; Cozzi G; Garcia-Oya I; Bucciarelli P; Boscarino M; Peyvandi F
    J Thromb Haemost; 2015 Oct; 13(10):1806-14. PubMed ID: 26206100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Type 2B von Willebrand Disease during Pregnancy.
    McLaughlin D; Kerr R
    Acta Haematol; 2017; 137(2):89-92. PubMed ID: 28118618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type 2B von Willebrand disease with or without large multimers: A distinction of the two sides of the disorder is long overdue.
    Casonato A; Daidone V; Galletta E; Bertomoro A
    PLoS One; 2017; 12(6):e0179566. PubMed ID: 28640903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential diagnosis of neonatal alloimmune thrombocytopenia: Type 2B von Willebrand disease.
    Penel-Page M; Meunier S; Fretigny M; Le Quellec S; Boisseau P; Vinciguerra C; Ternisien C; Rugeri L
    Platelets; 2017 Dec; 28(8):825-828. PubMed ID: 28436749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on type 2B von Willebrand disease.
    Mikhail S; Aldin ES; Streiff M; Zeidan A
    Expert Rev Hematol; 2014 Apr; 7(2):217-31. PubMed ID: 24521271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.
    Frontroth JP; Hepner M; Sciuccati G; Feliú Torres A; Pieroni G; Bonduel M
    Thromb Haemost; 2010 Dec; 104(6):1158-65. PubMed ID: 20941465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.
    Michiels JJ; van Vliet HH; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van der Velden A; Budde U
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):14-34. PubMed ID: 17164493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.
    Casonato A; Cattini MG; Daidone V; Pontara E; Bertomoro A; Prandoni P
    PLoS One; 2016; 11(8):e0161310. PubMed ID: 27532107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Differentiation of von Willebrand Disease Types 1 and 2 by von Willebrand Factor Multimer Analysis and DDAVP Challenge Test.
    Michiels JJ; Smejkal P; Penka M; Batorova A; Pricangova T; Budde U; Vangenechten I; Gadisseur A
    Clin Appl Thromb Hemost; 2017 Sep; 23(6):518-531. PubMed ID: 27443694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2B Hiroshima: a variant of von Willebrand disease characterized by chronic thrombocytopenia and the presence of all von Willebrand factor multimers in plasma.
    Takimoto Y; Imanaka F
    Int J Hematol; 1999 Aug; 70(2):127-31. PubMed ID: 10497852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of platelet type versus type 2B von Willebrand disease. An international registry-based study.
    Hamilton A; Ozelo M; Leggo J; Notley C; Brown H; Frontroth JP; Angelillo-Scherrer A; Baghaei F; Enayat SM; Favaloro E; Lillicrap D; Othman M
    Thromb Haemost; 2011 Mar; 105(3):501-8. PubMed ID: 21301777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?
    Favaloro EJ
    Semin Thromb Hemost; 2008 Feb; 34(1):113-27. PubMed ID: 18393148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.
    Othman M
    Semin Thromb Hemost; 2011 Jul; 37(5):464-9. PubMed ID: 22102188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease.
    Jilma B; Paulinska P; Jilma-Stohlawetz P; Gilbert JC; Hutabarat R; Knöbl P
    Thromb Haemost; 2010 Sep; 104(3):563-70. PubMed ID: 20589313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.